Zydus Lifesciences informs about press release

19 Dec 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated December 19, 2025, titled ‘Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India’. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

919.85 6.00 (0.66%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×